المؤلفون: Hitomi Sumiyoshi Okuma (11750045), Kan Yonemori (309164), Yuki Kojima (10346768), Maki Tanioka (411765), Kazuki Sudo (10336551), Emi Noguchi (4642618), Susumu Hijioka (9742107), Keiko Wakakuwa (11750048), Ken Kato (785312), Akihiro Hirakawa (309166), Aya Kuchiba (244882), Takashi Kubo (1269624), Hitoshi Ichikawa (760323), Akihiko Yoshida (281677), Yasushi Yatabe (245392), Kenichi Nakamura (11750051), Hiroyuki Mano (184613), Noboru Yamamoto (1484200), Yasuhiro Fujiwara (309173)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, rare cancer, CtDNA (circulating tumor DNA), precision medicine, soft tissue sarcoma, targeted therapy

Relation: https://figshare.com/articles/dataset/Table_1_Clinical_Utility_of_Circulating_Tumor_DNA_in_Advanced_Rare_Cancers_docx/17074334

الاتاحة: https://doi.org/10.3389/fonc.2021.732525.s002

المؤلفون: Hitomi Sumiyoshi Okuma (11750045), Kan Yonemori (309164), Yuki Kojima (10346768), Maki Tanioka (411765), Kazuki Sudo (10336551), Emi Noguchi (4642618), Susumu Hijioka (9742107), Keiko Wakakuwa (11750048), Ken Kato (785312), Akihiro Hirakawa (309166), Aya Kuchiba (244882), Takashi Kubo (1269624), Hitoshi Ichikawa (760323), Akihiko Yoshida (281677), Yasushi Yatabe (245392), Kenichi Nakamura (11750051), Hiroyuki Mano (184613), Noboru Yamamoto (1484200), Yasuhiro Fujiwara (309173)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, rare cancer, CtDNA (circulating tumor DNA), precision medicine, soft tissue sarcoma, targeted therapy

Relation: https://figshare.com/articles/dataset/DataSheet_1_Clinical_Utility_of_Circulating_Tumor_DNA_in_Advanced_Rare_Cancers_pdf/17074331

الاتاحة: https://doi.org/10.3389/fonc.2021.732525.s001

المؤلفون: Masahiro Tsuboi (11158958), Walter Weder (802091), Carles Escriu (10767514), Collin Blakely (4595182), Jianxing He (474805), Sanja Dacic (355596), Yasushi Yatabe (245392), Lingmin Zeng (5233187), Andrew Walding (11158961), Jamie E Chaft (9214790)

مصطلحات موضوعية: Cancer Therapy (excl. Chemotherapy and Radiation Therapy), EGFR-TKI-sensitizing mutations, EGFR-tyrosine kinase inhibitor, neoadjuvant, non-small-cell lung cancer, osimertinib, resectable

Relation: https://figshare.com/articles/figure/NeoADAURA_plain_language_summary_Neoadjuvant_osimertinib_with_without_chemotherapy_vs_chemotherapy_alone_for_EGFR_mutated_resectable_NSCLC_NeoADAURA_pdf/15022650

الاتاحة: https://doi.org/10.25402/fon.15022650.v1